Tags: cell | therapy | succeeds | ALS | study

Cell Therapy Succeeds in ALS Mid-Stage Study

Image: Cell Therapy Succeeds in ALS Mid-Stage Study
(Copyright iStock)

Monday, 18 Jul 2016 12:10 PM

Drug developer Brainstorm Cell Therapeutics Inc said its experimental cell therapy was found safe and well tolerated in patients with amyotrophic lateral sclerosis (ALS), a progressive neurological disorder, in a mid-stage study.

The New Jersey-based company's shares jumped 16 percent to $3.47 in premarket trading on Monday.

ALS is an invariably fatal neurological disease that attacks the nerve cells responsible for controlling voluntary muscles.

The drug, NurOwn, also showed a clinically meaningful benefit compared with a placebo, Brainstorm said.

© 2017 Thomson/Reuters. All rights reserved.

 
1Like our page
2Share
Health-News
Drug developer Brainstorm Cell Therapeutics Inc said its experimental cell therapy was found safe and well tolerated in patients with amyotrophic lateral sclerosis (ALS), a progressive neurological disorder, in a mid-stage study.The New Jersey-based company's shares jumped...
cell, therapy, succeeds, ALS, study
79
2016-10-18
Monday, 18 Jul 2016 12:10 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved